The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Natrilix SR 1.5 mg, prolonged-release film-coated tablets

Les Laboratoires ServierPA0568/005/001

Main Information

Trade NameNatrilix SR 1.5 mg, prolonged-release film-coated tablets
Active SubstancesIndapamide
Dosage FormProlonged-release tablet
Licence HolderLes Laboratoires Servier
Licence NumberPA0568/005/001

Group Information

ATC CodeC03BA Sulfonamides, plain
C03BA11 indapamide


License statusAuthorised
Licence Issued01/05/1996
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back